TOMATO-CAGE ANALYTICS LLC
Independent Meta-Analysis Reproducibility & Integrity Audits
We don't publish new meta-analyses.
We verify them.
A published conclusion is only as sound as the trials, assumptions, and studies pooled into it. We independently reproduce an existing meta-analysis, methodically changing one thing at a time, and report whether the headline conclusion actually holds
The Reproducibility Portfolio
1
Evidence Integrity Audit
Can questionable, retracted, or fabricated trials change the published conclusion?
RISK: Undetected for years
A prolific bone researcher had 14 papers retracted for fabricated data — but not before his trials had already been pooled into published meta-analyses. Two of those meta-analyses were later retracted outright because they rested entirely on that data; a third needed a formal published revision. Nobody checked the trials' integrity until a whistleblower did, years after the fact.
WE PROVIDE:
-
Every included trial checked against retraction databases and journal notices
-
Pooled estimate re-run with flagged trials excluded
-
Documented verdict: does the headline conclusion move, and by how much
Case reference: Vitamin K & fracture risk — Sato research-fraud case
2
Statistical Robustness Audit
How sensitive is the conclusion to the analyst's own assumptions?
RISK: Assumption-dependent
Meta-analyses of hydroxychloroquine for COVID-19 reached opposite conclusions depending on whether they pooled randomized trials only or blended in observational data — and the field was destabilized further when Surgisphere-sourced studies, briefly influential enough to pause a WHO trial arm, were retracted within days of independent scrutiny.
WE PROVIDE:
-
Inclusion criteria varied: RCT-only vs. all study designs
-
Effect model varied: fixed-effect vs. random-effects
-
Subgroup and outlier handling stress-tested, one change at a time
Case reference: hydroxychloroquine for COVID-19 scandal
3
Living Evidence Update
Does the original conclusion hold up over time when new research is added?
OUTCOME: Re-affirmed, updated
When the USPSTF updated its 2016 statin review in 2022, three newly eligible trials were added and the recommendation held — with more precision, not less. This is the model for a Living Evidence Update: rerun the original pooling logic against the full current literature and report whether the answer changed.
WE PROVIDE:
-
Updated literature search & evidence synthesis
-
Documented verdict: does the headline conclusion move, and by how much
Case reference:
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
How an audit runs
The four-step procedure, published in full alongside the verdict, so a third party could rerun it and get the same answer.
1 / SCOPE
Pin down the exact meta-analysis, version, and claim under review.
2 / REPRODUCE
Rebuild the original analysis from its own stated data and methods.
3 / SENSITIVITY ANALYSIS
Change one disclosed thing at a time — a trial, a model, a study design filter — and rerun.
4 / REPORT
A plain-language verdict plus a full methods trail anyone else could rerun.
Who this is built for:
Everyone asking "Is this evidence reliable?"
1 / Journals & systematic review teams
An independent second pass, run to fact-check and prevent the risk of a retraction notice.
2 / Pharma & medical affairs
Independent auditing to catch important and costly errors before launching an internal or public-facing product
3 / Policy, HTA & guideline bodies
Know whether the evidence continues to supports existing recommendations, keeping policies up-to-date with literature as time progresses and our body of knowledge updates
3 / Researchers catching AI-fabricated references
A fast "re-do" of an article after eliminating any AI-hallucinated or retracted studies, when corrections are needed